Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
New York Ventures
AddedFeb 13, 2024
UpdatedJul 16, 2026
New York Ventures

New York Ventures

Operating

NY-based capital firm specializing in international trade, energy, and real estate acquisition.

Location
New York City, NY, US
Founded
2015
Firm
Compare
Portfolio
Employees
Website

Investments

Dimensional Energy
Dimensional Energy

Total Raised

$48.7M

Rounds

12

Series A$20MDecember 2023
Zetagen Therapeutics
Zetagen Therapeutics

Total Raised

$14.4M

Rounds

6

Series B$9.8MAugust 2023
Series BOctober 2022
Ekostinger
Ekostinger

Total Raised

$2.7M

Rounds

9

Series UnknownMay 2023
Envisagenics
Envisagenics

Total Raised

$27.1M

Rounds

13

Series AMay 2023
C16 Biosciences
C16 Biosciences

Total Raised

$33.5M

Rounds

8

Series AApril 2023
MyndYou
MyndYou

Total Raised

$4M

Rounds

7

Series AApril 2023
Series AOctober 2022
Ursa Space Systems
Ursa Space Systems

Total Raised

$55M

Rounds

9

Series BApril 2023
Wats
Wats

Total Raised

$1.5M

Rounds

2

Pre-Seed$1.4MApril 2023
Otis AI
Otis AI

Total Raised

$6.4M

Rounds

8

Seed$1MApril 2023
BlocPower
BlocPower

Total Raised

$266.6M

Rounds

18

Series B$24MFebruary 2023
Series ASeptember 2022
Toggle
Toggle

Total Raised

$14.8M

Rounds

4

Series A$3MFebruary 2023
Kintra Fibers
Kintra Fibers

Total Raised

$9.9M

Rounds

2

Series A$7.9MJanuary 2023
JelikaLite
JelikaLite

Total Raised

$408.7k

Rounds

4

SeedDecember 2022
Bounce Imaging
Bounce Imaging

Total Raised

$9.5M

Rounds

13

Series ADecember 2022
Juno
Juno
Acquired

Total Raised

$28.4M

Rounds

5

Series A$12MDecember 2022
Series A$10.7MOctober 2022
CAHill TECH
CAHill TECH

Total Raised

$2M

Rounds

6

SeedNovember 2022
Exostellar
Exostellar

Total Raised

$34M

Rounds

7

Series A$12MNovember 2022
Inso Biosciences
Inso Biosciences

Total Raised

$2.8M

Rounds

7

Pre-SeedOctober 2022
Qunnect
Qunnect

Total Raised

$12.5M

Rounds

6

Series A$8MOctober 2022
GDI
GDI

Total Raised

$13.3M

Rounds

4

Series A$13.3MSeptember 2022
Hopscotch
Hopscotch

Total Raised

$8.1M

Rounds

4

Seed$8MSeptember 2022